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Abstract 
Objective: To examine the effects of feeding Bacillus subtilis C-3102 at the target inclusion rates of 0 
colony forming units (CFU) per g, 500,000 CFU per g, and 1 million CFU per g on intestinal health in 
weaned pigs after challenge with porcine epidemic diarrhea virus (PEDV). 
Materials and methods: A two-by-three factorial design was conducted, composed of three experimental 
diets and PEDV or sham challenge. Sixty 14-day-old pigs, negative for PEDV by quantitative real-time 
reverse transcription polymerase chain reaction (PCR) and negative by PCR for porcine reproductive and 
respiratory syndrome virus, were randomly allocated into six treatment groups with 10 pigs per group. 
Pigs were housed in groups of five in solid-floor pens. Treatment diets were fed for a total of 23 days, 
including 19 days before and 4 days after PEDV challenge or sham challenge by oral gavage. 
Results: Pathological changes associated with PEDV were significantly less severe in challenged 
treatment groups that received B subtilis C-3102 than in the group that received no B subtilis treatment. 
There were no significant differences in small intestinal length, ratio of small intestinal weight to body 
weight, colon dry matter content, average daily gain, or fecal scoring between any of the six treatment 
groups. 
Implication: Under the conditions of this study, treatment with B subtilis C-3102 in nursery pigs challenged 
with PEDV is associated with better enteric health than in pigs not treated with B subtilis C-3102. 
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Summary 
Objective: To examine the effects of feeding 
Bacillus subtilis C-3102 at the target inclu-
sion rates of 0 colony forming units (CFU) 
per g, 500,000 CFU per g, and 1 million 
CFU per g on intestinal health in weaned 
pigs after challenge with porcine epidemic 
diarrhea virus (PEDV).
Materials and methods: A two-by-three 
factorial design was conducted, composed of 
three experimental diets and PEDV or sham 
challenge. Sixty 14-day-old pigs, negative 
for PEDV by quantitative real-time reverse 
transcription polymerase chain reaction 
(PCR) and negative by PCR for porcine 
reproductive and respiratory syndrome 
virus, were randomly allocated into six treat-
ment groups with 10 pigs per group. Pigs 
were housed in groups of five in solid-floor 
pens. Treatment diets were fed for a total of 
23 days, including 19 days before and 4 days 
after PEDV challenge or sham challenge by 
oral gavage.
Results: Pathological changes associated 
with PEDV were significantly less severe in 
challenged treatment groups that received 
B subtilis C-3102 than in the group that 
received no B subtilis treatment. There were 
no significant differences in small intestinal 
length, ratio of small intestinal weight to 
body weight, colon dry matter content, aver-
age daily gain, or fecal scoring between any 
of the six treatment groups.
Implication: Under the conditions of this 
study, treatment with B subtilis C-3102 in 
nursery pigs challenged with PEDV is asso-
ciated with better enteric health than in pigs 
not treated with B subtilis C-3102.
Keywords: swine, porcine epidemic diar-
rhea virus, direct-fed microbials, Bacillus 
subtilis
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Resumen - Efecto de la alimentación di-
recta microbiana, Bacillus subtilis C-3102, 
en la salud entérica en cerdos de destete 
después del reto con el virus de la diarrea 
epidémica porcina
Objetivo: Examinar los efectos de la ali-
mentación con el Bacillus subtilis C-3102 en 
la índices meta de inclusión de 0 unidades 
formadoras de colonia (CFU por sus siglas 
en inglés) por g, 500,000 CFU por g, y 1 
millón de CFU por g en la salud intestinal 
en cerdos destetados después del reto con 
el virus de la diarrea epidémica porcina 
(PEDV).
Materiales y métodos: Se condujo un diseño 
factorial de dos por tres, compuesto de tres 
dietas experimentales y PEDV o reto falso. 
Sesenta cerdos de 14 días de edad, negativos al 
PEDV por medio de la reacción cuantitativa 
en tiempo real en cadena de la polimerasa 
con transcriptasa inversa cuantitativa en 
tiempo real (PCR por sus siglas en inglés) 
y negativa por medio de la PCR al virus del 
síndrome reproductivo y respiratorio porcino 
(PRRSV), se distribuyeron aleatoriamente en 
seis grupos de tratamiento con 10 cerdos por 
grupo. Los cerdos fueron alojados en grupos 
de cinco animales en corrales de piso sólido. 
Se alimentaron con las dietas tratamiento por 
un total de 23 días, incluyendo 19 días antes y 
4 días después del reto de PEDV o reto falso 
por medio de alimentación oral forzada.
Resultados: Los cambios patológicos asocia-
dos con el PEDV fueron significativamente 
menos severos en los grupos retados y con 
tratamiento que recibieron B subtilis C-3102 
que en el grupo que no recibió tratamiento con 
B subtilis. No hubo diferencias significativas en 
la longitud del intestino delgado, relación del 
peso del intestino delgado con el peso corporal, 
contenido de materia seca del colon, ganancia 
diaria promedio, o puntaje fecal entre cualqui-
era de los seis grupos de tratamiento.
Implicacione: Bajo las condiciones de este 
estudio, el tratamiento con B subtilis C-3102 
en cerdos de destete retados con el PEDV se 
asocia con mejor salud entérica que en cerdos 
no tratados con B subtilis C-3102.
Résumé - Effet de l’administration orale 
de Bacillus subtilis C-3102 sur la santé en-
térique de porcelets en pouponnière suite 
à une infection avec le virus de la diarrhée 
épidémique porcine
Objectif: Examiner les effets de 
l’administration orale de Bacillus subtilis 
C-3102 à la dose cible d’inclusion de 0 unité 
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Porcine epidemic diarrhea virus (PEDV) was first detected in North America in April 2013 and since then 
has been diagnosed in over 30 US states, 
with more than 9000 confirmed cases.1 It is 
well understood that PEDV affects intesti-
nal health by producing atrophic enteritis 
through viral destruction of enterocytes.1,2 
Infected suckling and nursery pigs experi-
ence a maldigestive and malabsorptive 
diarrhea resulting in acute dehydration, and 
increased risk of septicemia due to decreased 
intestinal barrier functions. The severity of 
clinical signs is age dependent, with piglets 
less than 7 days of age demonstrating the 
most severe diarrhea and mortality rates.1,2 
Many swine production groups and stake-
holders are interested in products that miti-
gate clinical signs and reduce intestinal pa-
thology associated with PEDV. In addition 
to biologics and supportive fluid therapy, 
direct-fed microbials (DFMs) may present 
an alternative option to supportive therapy 
for PEDV-infected pigs. Direct-fed microbi-
als, which are readily accessible to producers 
and easily incorporated into feed rations 
for adult and growing animals, have been 
investigated in the food-animal literature for 
their effects in improving intestinal health, 
feed efficiency, and meat quality, and modi-
fying fecal consistency.3,4 Targeted studies5,6 
have investigated the effects of DFMs on 
pathogen shedding and mitigating clinical 
signs caused by enteric pathogens, includ-
ing Salmonella serovars and Escherichia coli. 
Common commercially available DFM 
products are strain specific and include 
yeasts and (or) bacteria, specifically Bacillus 
species and (or) Lactobacillus species. To 
date, we have been unable to find publically 
available peer-reviewed literature describing 
the effects of DFMs on intestinal health and 
pathology following challenge with or expo-
sure to PEDV. As PEDV is a contemporary 
pathogen with several well developed chal-
lenge models, an assessment of the utility of 
DFMs in mitigating the effects of the disease 
was warranted and relevant to modern pig 
production.3,7,8
The focus of this study was on Bacillus subti-
lis C-3102 (Calsporin; Calpis Co Ltd, Japan 
and Quality Technology International, 
Huntley, Illinois), which is a gram-positive, 
catalase-positive, rod-shaped obligate aer-
obe that is stable in extreme environmental 
conditions.9 It has a history of use in swine 
since 1981 and is manufactured as a com-
mercial product available to the US swine 
industry.10
The objective of this study was to examine 
the effects on intestinal health and pathol-
ogy of feeding B subtilis C-3102 prior to and 
during a PEDV challenge in weaned pigs. 
The targeted inclusion rates studied were 0 
colony-forming units (CFUs) per g, 500,000 
CFUs per g, and 1 million CFUs per g.
Material and methods
This study was approved by the Iowa State 
University Institutional Animal Care and 
Use Committee.
Animals and housing
Sixty 14-day old, high health status barrows 
(30) and gilts (30) were sourced from a pri-
vate commercial provider in Iowa. Fourteen-
day-old weaned piglets were selected to 
ensure that pigs would be sufficiently young 
at PEDV inoculation to experience clinical 
signs, and because suckling pigs would not 
have substantial feed intake while on the 
sow. Pigs and their dams had no history of 
PEDV or porcine deltacoronavirus exposure 
or clinical signs and were considered naive 
to these pathogens. Pigs were housed at the 
Iowa State University Laboratory Animal 
Resources Facility in 12 different rooms, 
five pigs per room, with two rooms for each 
treatment group. The rooms had solid floors, 
and each contained one water nipple and 
feeder. Pigs were fed ad libitum in a plastic 
pan-style feeder with 61 cm of tray length 
divided into three feeding spaces. Gruel feed 
was offered for the first 3 days of the study to 
ease the transition from milk to solid food. 
Floor space per animal met the require-
ments set in the Guide for the Care and Use 
of Agricultural Animals in Research and 
Teaching.11
Study design
Treatment allocation. Upon arrival, pigs 
were each weighed and given a uniquely 
numbered plastic livestock ear tag placed 
in the right ear (Allflex, Dallas, Texas). Pigs 
were randomized to treatment groups and to 
individual rooms using the random number 
generator function in Microsoft Excel (Mi-
crosoft, Redmond, Washington). The 60 pigs 
were each randomly allocated to one of the six 
treatment groups (Table 1), with 10 pigs per 
treatment group (five barrows and five gilts).
This was a 2 × 3 factorial design involv-
ing three experimental diets and PEDV or 
sham challenge. The experimental diets were 
standard, commercially prepared, antibiotic-
free nursery pig diets containing Bacillus 
subtilis C-3102 (Calsporin at 0, 500,000, or 
1 million CFUs per g). Groups were chal-
lenged with either PEDV-positive or PEDV-
negative cell-culture fluids by oral gastric 
gavage. Table 1 displays the six treatment 
groups represented in this design. Pigs were 
acclimated to the research facilities and solid 
feed for 3 days. The study diets were then 
fed for 19 days and pigs were inoculated 
with PEDV-positive or PEDV-negative cell-
culture fluid on day 22. On the basis of the 
manufacturer’s recommendations, optimal 
gastrointestinal effect was anticipated after 
feeding for 14 to 21 days, which thus was 
selected as the targeted duration of feeding 
before inoculation with PEDV.
Four days after inoculation (day 26), pigs 
were euthanized and necropsied. The pigs 
remained on the treatment diets up to and 
formatrice de colonie (UFC) par g, 500,000 
UFC par g, et 1 million UFC par g sur la 
santé intestinale de porcelets sevrés suite à 
une infection défi avec le virus de la diarrhée 
épidémique porcin (VDEP).
Matériels et méthodes: Une étude avec un 
plan factoriel de 2 × 3 a été menée, composé de 
trois diètes expérimentales et une infection défi 
avec VDEP ou une infection simulée. Soixante 
porcs âgés de 14 jours, négatifs pour le VDEP 
par réaction d’amplification en chaîne quanti-
tative (PCR) en temps réel avec la polymérase 
réverse et négatif par PCR pour le virus du 
syndrome reproducteur et respiratoire porcin 
(VSRRP), ont été répartis de manière aléatoire 
en six groupes de traitement de 10 porcs par 
groupe. Les porcs étaient logés en groupe de 
cinq porcs dans des parcs avec des planchers 
pleins. Les diètes ont été données aux groupes 
sous traitement pour un total de 23 jours, 19 
jours avant et 4 jours après le challenge avec le 
VDEP ou l’infection simulée par gavage oral.
Résultats: Les changements pathologiques 
associés avec le VDEP étaient significativement 
moins sévères dans les groupes infectés ayant 
reçu B subtilis C-3102 comparativement aux 
groupes n’ayant pas reçu de traitement avec 
B subtilis C-3102. Il n’y avait aucune différence 
significative dans la longueur du petit intestin, 
le ratio du poids du petit intestin sur le poids 
corporel, le contenu en matière sèche du côlon, 
le gain moyen quotidien, ou le pointage fécal 
entre les six groupes de traitement.
Implication: Dans les conditions de la 
présente étude, le traitement avec B subtilis 
C-3102 de porcs en pouponnière infectés 
avec VDEP est associé avec une meilleure 
santé entérique que chez des porcs non trai-
tés avec B subtilis C-3102.
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Table 1: Pigs fed Bacillus subtilis C-3102 at one of three concentrations in the feed for 19 days were then administered, by 
gavage, cell culture either positive (three groups) or negative (three groups) for porcine epidemic diarrhea virus (PEDV)*
Treatment group Inoculum† Diet treatment
1 PEDV-negative cell culture None
2 PEDV-negative cell culture B subtilis C-3102, 500,000 CFU/g
3 PEDV-negative cell culture B subtilis C-3102, 1,000,000 CFU/g
4 PEDV-positive cell culture None
5 PEDV-positive cell culture B subtilis C-3102, 500,000 CFU/g
6 PEDV-positive cell culture B subtilis C-3102, 1,000,000 CFU/g
*  2 × 3 factorial design with 10 pigs randomly allocated to each dietary treatment group for a total of 60 pigs. Pigs weaned at 14 days of age 
were each fed B subtilis C-3102 (Calsporin; Calpis Co Ltd, Japan and Quality Technology International, Huntley, Illinois) for 19 days at one of 
three concentrations in the feed. On day 20 of feeding treatment diets, pigs received cell culture either positive or negative for PEDV by oral 
gavage. Four days after inoculation, pigs were euthanized by captive bolt and intestinal samples were collected.
†  PEDV in cell culture was confirmed by quantitative real-time reverse transcription polymerase chain reaction testing.
      CFUs = colony-forming units.
 
including the day of necropsy, totaling 23 days 
on the experimental diets.
Pre-trial processing
On day 1 of the study, blood and fecal swabs 
were collected from each pig. Whole blood 
was collected by jugular venipuncture into 
a serum separator tube. Whole blood was 
centrifuged at 2000g for 10 minutes and 
serum was poured into plastic snap cap 5-mL 
serum tubes. Polyester-tip swabs were used 
to collect fecal samples. Swabs were then 
placed in 1 mL of sterile phosphate buffered 
saline (PBS) in a 5-mL snap cap tube. Serum 
and fecal samples were submitted to the 
Iowa State University Veterinary Diagnostic 
Laboratory (ISU VDL). The following as-
says were performed: PRRSV polymerase 
chain reaction (PCR)12 was performed on 
serum samples pooled in groups of five. Ad-
ditionally, PEDV13 and PRRSV12 enzyme-
linked immunosorbent assays (ELISAs) were 
performed individually on serum samples. 
Fecal swabs were pooled in groups of five, and 
PEDV PCR1,8 was performed on each pool. 
Pigs included in the trial did not consume wa-
ter or feed with antibiotics for at least 7 days 
prior to the beginning of the trial, and had no 
prior injectable antibiotic treatments before 
the trial start date.
Feed and water
Heartland Co-op (Waukee, Iowa) provided 
three custom grind and mix diets for the 
trial (B subtilis C-3102 at 0, 500,000, and 
1 million CFU per g). The diets contained 
no antibiotics and met the National Re-
search Council nutrition requirement for 
pigs.14 The diets were produced at the 
mill in 453-kg batches. One 22.7-kg bag 
of B subtilis C-3102 (Calsporin 2.0B lot 
190588) containing 412.3 billion CFU per 
kg of B subtilis C-3102, guaranteed analysis, 
was supplied to the feed mill and incorpo-
rated into the rations as per label instruc-
tions for each given concentration. The three 
rations were then processed into 22.7-kg bags 
labeled with the corresponding B subtilis 
C-3102 concentration. The feed was stored in 
bins with locking lids in each room. Correct 
diet allocation to each study room was veri-
fied by two people, independently, each day. 
Commercial nursery phase-one starter pellets 
without B subtilis C-3102 or antibiotics were 
fed during the first 3 days of the acclimation 
period. After the acclimation period, the pigs 
were started on the B subtilis C-3102 diets ad 
libitum and continued on these diets for the 
remainder of the trial. Daily feed and water 
samples were collected from each room and 
stored at -20°C for further analysis if needed.
Porcine epidemic diarrhea virus 
(PEDV) challenge
On day 22 of the trial, the sham challenge 
(groups 1, 2, 3) and the PEDV challenge 
(groups 4, 5, 6) were performed by oro-
gastric gavage using an 18 French rubber 
catheter. Each pig in treatment groups 1, 
2, and 3 was inoculated with 10 mL of a 
PEDV-negative virus culture medium. Each 
pig in treatment groups 4, 5, and 6 was chal-
lenged with 10 mL of PEDV-positive cell 
culture containing 104 median tissue culture 
infective doses (TCID50) of PEDV per 
mL. Ten-mL aliquots of PEDV-positive and 
PEDV-negative inoculum were collected at 
the time of inoculation and submitted for 
PEDV PCR to confirm status.
Biological sample collection
Pig weights and fecal swabs. Pig weights 
were obtained on arrival (day 0), at com-
mencement of study diets (day 3), on day of 
inoculation (day 22), and on day of necropsy 
(day 26). At each weigh point, the scale was 
calibrated with a 20-kg calibration weight. 
Average daily gain (ADG) was calculated for 
the 23 days of the study period and reflected 
the time in which pigs were fed the treat-
ment diets (day 3 to day 26).
Fecal swabs were collected on arrival (day 0), 
at commencement of feeding study diets  
(day 3), after 11 days (day 14) and 18 days 
(day 21) on the study diet, on day of inocula-
tion (day 22), at 2 and 3 days post inoculation 
(dpi), and on the day of necropsy (day 26). 
Fecal swabs collected at necropsy (4 dpi) were 
tested individually for PEDV by quantita-
tive real-time reverse transcription PCR. The 
remaining swabs were stored at -80°C for 
further analysis if needed.
Sample collection at necropsy. Four days 
after inoculation, all pigs were euthanized 
by captive bolt and exsanguination and nec-
ropsied. If gross pathology was observed at 
necropsy, observations were recorded and 
fresh and fixed tissues of affected organs 
were collected for diagnostic testing. Each 
pig’s gastrointestinal tract was then removed. 
Zip ties were placed 1 cm distally from the 
junction of the stomach and duodenum 
and 1 cm proximal to the ileocecal junction 
to standardize removal between pigs. The 
intestines were separated from body wall 
attachments and laid out on a necropsy 
table. The large intestine was then removed. 
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Milking out the contents of the intestines 
was possible, but was not performed due to 
concern about disrupting intestinal mucosa 
for fixation and histopathologic examina-
tion. The entire length of the small intestine 
was measured and recorded. As the small 
intestine was susceptible to elongation from 
manual manipulation, the tension applied to 
the intestine might have greatly affected the 
measured length. To mitigate variation, two 
people were solely responsible for measur-
ing small intestinal length (SIL) and were 
trained to apply equal tension to facilitate 
consistency between measurers. The weight 
of the gastrointestinal tract was recorded 
on a digital 500-g × 0.01-g scale that was 
calibrated with a 100-g calibration weight. 
Small intestine weight-body weight (SIWB) 
is the weight of the small intestine divided 
by body weight to create a standardized 
weight for each pig, which was then used in 
the statistical models. 
The small intestinal tract was folded on itself 
to create four segments of equal length in a 
W formation. From the proximal end, the 
sample sites were duodenum (W1), proxi-
mal jejunum (W2), mid-jejunum (W3), 
distal jejunum (W4), and ileum (W5). Two 
1-cm sections were collected at each of the 
five sites for fresh and fixed tissues.
Immunohistochemistry
Histopathology slides were prepared for 
PEDV immunohistochemistry (IHC) for 
each of the five small intestinal sections of 
all pigs as described in Madson et al.1 Viral 
antigens (PEDV) were detected and semi-
quantitatively scored1 on the basis of the 
following criteria: 0 = no signal; 1 = 1% to 
10% of villous enterocytes within section 
showing a positive signal; 2 = 11% to 50% of 
villous enterocytes showing a positive signal; 
and 3 = 51% or more of villus enterocytes 
showing a positive signal.1 All scoring was 
performed by a veterinary pathologist blind-
ed to treatment allocation.
Histopathology and atrophic  
enteritis scoring
A veterinary pathologist, blinded to treat-
ment allocation, measured three perceived 
full-length villi and crypts per section using 
a computerized image system (Olympus 
DP72 camera, cellSens digital imaging soft-
ware, Olympus, Waltham, Massachusetts). 
The mean villus length and crypt depth were 
calculated for each segment and used to de-
termine villus height-to-crypt-depth ratios 
(VCR).1 Atrophic enteritis (AE) scoring was 
performed for each of the five small intesti-
nal sections of each pig. Scores were based 
on the following criteria: 0 = no enteritis 
observed; 1 = mild atrophic enteritis; 2 = 
moderate atrophic enteritis; and 3 = severe 
atrophic enteritis. Scoring was performed 
by a single veterinary pathologist blinded to 
treatment allocation.
Inoculum preparation
To generate the inoculum, PEDV US proto-
type strain isolate USA/IA19338/2013 was 
propagated and virus concentration was de-
termined on Vero cells (ATCC CCL-81).15 
The eighth passage of the virus on cell cul-
ture was diluted with post-inoculation medi-
um to a final concentration of 104 TCID50 
per mL and stored at -80°C upon use.15
Porcine epidemic diarrhea virus 
PCR and quantitation
A previously described PEDV nucleocapsid 
(N) gene-based qualitative real-time reverse 
transcription PCR (qRT-PCR) was used 
in this study for the detection of PEDV 
RNA.1,8,15,16 Polymerase chain reaction 
amplification was performed using Path-ID 
Multiplex One-Step RT PCR kit (Thermo 
Fisher Scientific, Carlsbad, California) on 
an Applied Biosystem 7500 fast instrument 
(Thermo Fisher Scientific) and analyzed by 
system software. Serial 10-fold dilutions of 
in vitro transcribed RNA standards were 
used in the PEDV N gene-based qRT-PCR 
to generate standard curves and quantify 
viral loads (genome copies per mL) in test 
samples.8  Results of PCR testing were re-
ported as cycle threshold (Ct) values, with 
Ct values ≥ 36 considered negative.
Cecum and colon dry matter (DM)
Cecum and colon contents were milked out 
into separate sterile sample containers. These 
specimens were frozen at -20°C and then 
submitted for DM analysis. Digital photo-
graphs of the colon contents were taken for 
fecal consistency scoring.
Determination of cecum and colon DM 
was performed under standard operating 
protocols and supervision of one of the 
authors (SG). Cecum and colon contents 
were thawed over a 24-hour period, and 
15 g of each sample was weighed out on a 
500-g × 0.01-g scale. A volume of 20 mL 
of 1:32 accelerated hydrogen peroxide 
(Accel disinfectant; Virox Technologies 
Inc, Oakville, Ontario, Canada) was added 
to each sample. Aluminum pans were used 
to weigh out two 5.00-g aliquots of cecal 
contents on a 200-g × 0.01-g scale. This was 
repeated for colon contents of each pig. All 
samples were placed in a large convection 
oven (Yamato Mechanical Convection Oven, 
model DKN810, Santa Clara, California) at 
20.6°C. At 48 hours, samples were removed 
and placed into a plastic desiccator to cool, 
and then weighed again on the 200-g × 0.01-g 
scale. The following equation to determine 
DM percentage equals
dry weight – pan weight
wet weight – pan weight
× 100 
The mean DM of the two aliquots for each 
pig for both cecum and colon was calculated.
Fecal scoring methods 
Photographs of colon contents were taken 
for each pig and assigned a fecal consistency 
score by a veterinarian using the photo-
graphs and blinded to treatment allocation. 
Fecal consistency was scored on a scale of  
1 to 4, where 1 = normal; 2 = mild diarrhea; 
3 = moderate diarrhea; and 4 = severe  
watery diarrhea.
Statistical analysis
Responses were analyzed using linear 
mixed models for each variable of interest. 
For analyses of intestinal variables, IHC, 
AE, VCR, PEDV genome copies per mL, 
treatment group, intestinal segment, and 
their interactions were used as fixed effects, 
whereas room and animal were used as ran-
dom effects. A natural log transformation for 
the response variable PEDV genome copies 
per mL was performed to meet normality 
assumptions for its generalized linear mixed 
model. For the analyses of the following vari-
ables (ADG, cecum dry matter, colon dry 
matter, small intestine length, small intestine 
weight per kg body weight, and fecal score), 
treatment group was the fixed effect and 
room was the random effect. Comparisons 
among groups were assessed using F-tests 
followed by Tukey’s t tests for multiple 
comparisons. Differences were considered 
significant at P < .05. All analysis was per-
formed on SAS 9.4 (SAS institute Inc, Cary, 
North Carolina).
Results
Pre-trial contamination screening
Samples collected from all pigs on the day 
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of arrival were negative by PRRSV pooled 
PCR and individual PRRSV ELISAs on 
serum. Porcine epidemic diarrhea virus 
PCR tests on pooled fecal swabs and PEDV 
ELISA tests on serum were also all negative. 
For samples collected on the day of inocula-
tion, pools of fecal swabs from all groups 
and PEDV-negative cell culture inoculum 
were PEDV-negative on PCR.
Clinical assessment
Pigs were generally healthy and active and 
there was no mortality during the trial. Fecal 
staining of pen walls or pigs, acute dehydra-
tion, vomiting, and lethargy were not ob-
served in any treatment group after inocula-
tion with PEDV.
Gross pathology
For PEDV-positive groups and at all diet 
inclusion levels of B subtilis C-3102, the 
small intestines were thin, dilated, and filled 
with watery ingesta. In the PEDV-negative 
groups, no gross lesions were noted for the 
small intestine at necropsy.
Immunohistochemistry 
(IHC) score
Results for pairwise comparisons of IHC 
scores between treatment groups are pre-
sented in Table 2 for each intestinal segment. 
There were significant differences in IHC 
scores between groups 4 and 5 and 4 and 6 
for several segments. There were no signifi-
cant differences in the IHC scores for any 
intestinal segments between groups 1 and 2, 
1 and 3, 1 and 5, 2 and 3, 2 and 5, 3 and 5, 
and 5 and 6.
Villus-to-crypt (VCR) ratio
Table 3 presents comparisons of VCRs be-
tween treatment groups for each segment. 
Villus-to-crypt ratios were significantly 
higher in groups 1, 2, and 3 (all PEDV-
negative) than in Group 4 (PEDV-positive), 
and were significantly lower in Group 4 than 
in Group 5.
Atrophic enteritis (AE)
Table 4 reports significant pairwise compari-
sons of AE score for each segment between 
treatment groups. Atrophic enteritis score 
was significantly higher in group 4 than in 
groups 5 and 6 for several segments within 
each comparison.
Quantitative real-time reverse tran-
scription PCR for porcine epidemic 
diarrhea virus
The PEDV-positive cell-culture inoculum 
was PEDV-positive (cycle threshold value 
= 17.5). For fecal swabs collected on day 4 
post inoculation, treatment groups 1, 2, and 
3 tested PEDV-negative by PCR. Treatment 
groups 4, 5, and 6 were PEDV PCR-positive 
and further quantification was performed 
on each individual swab. Mean log PEDV 
genome copies per mL and standard error 
(in parenthesis) for groups 4, 5, and 6 were 
19.18 (3.35), 13.29 (3.35), and 15.66 (3.35). 
None of the differences in pairwise compari-
sons between treatment groups were signifi-
cant at P < .05 for mean log genome copies 
per mL of feces.
Table 2: Mean differences* and P values† for pairwise comparisons of porcine epidemic diarrhea virus (PEDV) immunohisto-
chemistry (IHC) scores between treatment groups for each of the five intestinal segments assessed (W1 to W5)
Groups
W1 W2 W3 W4 W5
Difference (P) Difference (P) Difference (P) Difference (P) Difference (P)
1 2 0 (1) 0 (1) 0 (1) 0 (1) 0 (1)
1 3 0 (1) 0 (1) 0 (1) 0 (1) 0 (1)
1 4 -1 (< .001) -2.4 (< .001) -2.3 (< .001) -2.3 (< .001) -2 (< .001)
1 5 -0.2 (.64) -0.5 (.24) -0.5 (.24) -0.5 (.24) -0.4 (.35)
1 6 -0.4 (.35) -0.9 (.04) -0.9 (.04) -0.9 (.04) -0.9 (.04)
2 3 0 (1) 0 (1) 0 (1) 0 (1) 0 (1)
2 4 -1 (< .001) -2.4 (< .001) -2.3 (< .001) -2.3 (< .001) -2 (< .001)
2 5 -0.2 (.64) -0.5 (.24) -0.5 (.24) -0.5 (.24) -0.4 (.35)
2 6 -0.4 (.35) -0.9 (.04) -0.9 (.04) -0.9 (.04) -0.9 (.04)
3 4 -1 (< .001) -2.4 (< .001) -2.3 (< .001) -2.3 (< .001) -2 (< .001)
3 5 -0.2 (.64) -0.5 (.24) -0.5 (.24) -0.5 (.24) -0.4 (.35)
3 6 -0.4 (.35) -0.9 (.04) -0.9 (.04) -0.9 (.04) -0.9 (.04)
4 5 0.8 (.06) 1.9 (< .001) 1.8 (< .001) 1.8 (< .001) 1.6 (.002)
4 6 0.6 (.16) 1.5 (< .001) 1.4 (< .01) 1.4 (< .01) 1.1 (.01)
5 6 -0.2 (.64) -0.4 (.35) -0.4 (.35) -0.4 (.35) -0.5 (.24)
*  Treatment groups described in Table 1. Mean IHC scores were compared between treatment groups listed in the first two columns for 
each of the five intestinal segments assessed (W1 to W5). Intestinal segments examined: duodenum (W1), proximal jejunum (W2), mid-
jejunum (W3), distal jejunum (W4), and ileum (W5).
†  P refers to the P value for the difference in mean IHC scores between the two groups listed on each row, generated from Tukey’s adjust-
ment for multiple comparisons. Pooled standard error, 0.4. P values < .05 (bold print) were considered statistically significant.
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Macroparameters of gut health 
Cecum and colon dry matter. Mean cecum 
and colon DM percentages were determined 
and pairwise comparisons of DM percent-
ages for both cecum and colon samples 
revealed several statistically significant differ-
ences reported in Table 5.
Fecal score. Mean fecal score was recorded; 
however, there were no significant differ-
ences in fecal consistency for all pairwise 
comparisons of the six treatment groups  
(P ≥ .05).
Small intestine weight by body weight 
(SIWB) and SIL. There were no significant 
differences in least squares mean SIWB or 
SIL between pairwise comparisons of all 
groups.
Average daily gain. Pairwise comparisons 
between treatment groups for 23-day ADG 
using Tukey’s least squares means adjust-
ment for multiple comparisons were not sig-
nificantly different for any of the treatment 
groups.
Discussion
The literature available on the effects of 
DFMs on enteric disease or on reducing 
shedding of pathogens is limited. Trials as-
sessing the effect of Lactobacillus species 
on fecal shedding of enteric pathogens and 
ADG in Salmonella Typhimurium and rota-
virus challenge models have shown limited 
positive effects on study outcomes.5,6  There 
is also currently a patent (WO 2005007834 
A1) submitted for a Lactobacillus species 
with the claim that this strain can inhibit 
growth of enteric coronavirus in vitro. Sow 
fecal shedding, piglet mortality, and piglet 
diarrhea were assessed in sows and gilts fed 
B subtilis C-3102 for 3 weeks at 107 CFUs 
per gram of feed.17 Sows receiving B subtilis 
C-3102 experienced a reduction in Clos-
tridium perfringens fecal shedding and an 
increase in lactobacilli fecal shedding after 
21 days of continuous exposure to the diet. 
Bacillus subtilis C-3102 is also reported to 
have a positive effect on sow feed consump-
tion, wean-to-estrus interval, piglet birth 
weight, and fecal shedding of Escherichia coli 
and Clostridium species.18 Upon review of 
the literature, comparable studies examining 
associations between B subtilis C-3102 and 
intestinal histopathology and macroparame-
ters of gut health following PEDV infection 
were not found.
Significant differences in IHC score be-
tween Group 1 and Group 4 on control 
diets indicated that the PEDV challenge did 
cause enteric infection with PEDV in the 
study pigs. Mean IHC scores for Group 4 at 
4 dpi were comparable to those reported for 
3-week-old pigs.1 For PED-positive groups, 
those fed B subtilis C-3102 (groups 5 and 6) 
had lower IHC scores than those fed control 
diets (Group 4), indicating that there was 
a lower percentage of enterocytes infected 
with PEDV in groups 5 and 6. The mecha-
nism for this difference in IHC scores is un-
known and pigs were not followed beyond  
4 dpi to evaluate the duration and magni-
tude of this difference over a longer time 
period. There was no statistical difference in 
IHC scores between Group 5 and Group 6, 
although both were significantly lower than 
in Group 4. This suggests that the effect on 
IHC may not be dependent on dietary  
Table 3: Mean differences* and P values† for pairwise comparisons of villus height-to-crypt-depth ratios (VCRs) between treat-
ment groups for each of the five intestinal segments assessed (W1 to W5)
Groups
W1 W2 W3 W4 W5
Difference (P) Difference (P) Difference (P) Difference (P) Difference (P)
1 2 -0.011 (.96) -0.580 (.01) -0.334 (.15) -0.345 (.13) -0.146 (.53)
1 3 0.492 (.03) -0.294 (.20) -0.100 (.66) -0.112 (.62) -0.0554 (.81)
1 4 0.395 (. 09) 0.715 (.002) 0.624 (.01) 0.500 (.03) 0.358 (.12)
1 5 -0.027 (.91) 0.261 (.26) 0.0351 (.88) -0.0860 (.71) -0.139 (.54)
1 6 0.123 (.59) 0.474 (.04) 0.482 (.04) 0.322 (.16) 0.270 (.24)
2 3 0.503 (.03) 0.285 (.21) 0.235 (.31) 0.233 (.31) 0.091 (.69)
2 4 0.406 (.08) 1.30 (< .001) 0.958 (< .001) 0.845 (< .001) 0.504 (.03)
2 5 -0.0161 (.94) 0.841 (< .001) 0.369 (.11) 0.259 (.26) 0.0066 (.98)
2 6 0.134 (.56) 1.05 (< .001) 0.816 (.001) 0.667 (< .01) 0.416 (.07)
3 4 -0.0974 (.67) 1.01 (< .001) 0.723 (< .01) 0.612 (.01) 0.414 (.07)
3 5 -0.519 (.02) 0.555 (.02) 0.135 (.56) 0.0263 (.91) -0.084 (.71)
3 6 -0.370 (.11) 0.768 (< .001) 0.581 (.01) 0.434 (.06) 0.325 (.16)
4 5 -0.422 (.07) -0.454 (.04) -0.588 (.01) -0.586 (.01) -0.498 (.03)
4 6 -.272 (.23) -0.242 (.29) -0.142 (.54) -0.178 (.44) -0.0883 (.70)
5 6 0.150 (.51) 0.213 (.35) 0.446 (.05) 0.408 (.08) 0.409 (.08)
*  Treatment groups are described in Table 1. Mean VCRs were compared between treatment groups listed in the first two columns for each 
of the five intestinal segments assessed. Intestinal segments examined: duodenum (W1), proximal jejunum (W2), mid-jejunum (W3), distal 
jejunum (W4), and ileum (W5).
†  P refers to the P value for the difference in mean VCRs between the two groups listed on each row, generated from Tukey’s adjustment for 
multiple comparisons. Pooled standard error, 0.229. P values < .05 (bold print) were considered statistically significant.
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concentration of B subtilis C-3102. The 
sample size of this study was small and the 
study had insufficient power to elucidate 
and quantify a dose-dependent relationship 
between Group 4 and Group 5 compared to 
Group 4 and Group 6. This represents an area 
for future studies to investigate further.
The findings described in the comparisons 
between treatment groups for IHC scores 
were also identified in the atrophic enteritis 
scores. As atrophic enteritis is a pathologic 
lesion association with enteric viral patho-
gens, and IHC is a quantitative measure 
of PEDV infection of the enterocytes, it 
is logical that these scores would mirror 
each other. In treatment Group 3, there was 
mild atrophic enteritis in the W1 and W3 
segments. As these segments were IHC-
negative for PEDV, and the fecal swabs from 
these pigs were PEDV-negative on PCR, 
this mild enteritis could be attributed to 
other enteric viruses such as rotavirus, or to 
enteric inflammation related to diet or to 
other bacterial pathogens.
In swine, B subtilis increases the prevalence 
of bacterial colonization with Streptococcus 
species, Bifidobacterium species, and Lacto-
bacillus species, which may act to competi-
tively exclude pathogens from colonizing the 
mucosal surface.3,10,19 Lactobacilli produce 
lactic acid, which lowers gut pH and opti-
mizes the gut environment for commensal 
bacteria.3,6 Bacillus species also produce 
catalases and proteases that may serve as 
exogenous digestive enzymes. These enzymes 
can alter the protein content of gut ingesta 
and create optimal conditions for Lactobacil-
lus colonization and growth.20 The resultant 
decrease in intestinal pH and increase of 
commensal bacteria may impact the ability 
of PEDV to infect enterocytes and may ex-
plain the lower IHC scores in Group 4 than 
in Group 5 or Group 6.
Values for VCR for each intestinal region 
were uniformly smaller, across all six treat-
ment groups, than those reported for 
3-week-old pigs.1,21 Pigs in this study were 
approximately 5 weeks old at the time of 
necropsy. Villus-crypt ratio is dependent on 
age, diet, and genetic factors,1 thus the lower 
VCR observed here for all treatment groups 
(1, 2, 3, 4, 5, and 6) may reflect a difference 
in pig age between the studies.
There was a significantly lower VCR for 
PEDV-challenged pigs in Group 4 com-
pared to those that were sham challenged 
(groups 1, 2, and 3). Villus length and crypt 
depth are highly dynamic and reflect local 
insult and subsequent regeneration. The 
VCR provides a snapshot of current status of 
the villi and crypts at the time of necropsy, 
and the VCR is expected to increase post 
inoculation as the pig recovers.1,7 Although 
VCRs were significantly higher in PEDV-
positive pigs fed B subtilis C-3102 than in 
controls, the clinical significance of this 
finding in terms of ADG and morbidity 
is unclear. It would be necessary to stagger 
necropsies over several dpi and extend the 
duration of the study to assess the long-term 
effect of B subtilis C-3102 on VCR after 
PEDV challenge.
In this study, quantitation of the PEDV 
challenge was used to verify that the chal-
lenge dose was homologous between groups. 
Groups 4, 5, and 6 were all PEDV-positive at 
4 dpi and there were no significant differences 
in genome copies per mL shed in the feces. 
This indicates that continuously feeding pigs 
Table 4: Mean differences* and P values† for pairwise comparisons of atrophic enteritis (AE) scores between treatment groups 
for each of the five intestinal segments assessed
Groups
W1 W2 W3 W4 W5
Difference (P) Difference (P) Difference (P) Difference (P) Difference (P)
1 2 0 (1) 0 (1) 0 (1) 0 (1) 0 (1)
1 3 -0.5 (.16) 0 (1) -0.1 (.78) 0 (1) 0 (1)
1 4 -1.2 (< .001) -2 (< .001) -1.6 (< .001) -1.6 (< .001) -1.4 (< .001)
1 5 -0.4 (.26) -0.4 (.26) -0.2 (.57) -0.1 (.78) -0.2 (.57)
1 6 -0.7 (.049) -1.1 (< .01) -0.8 (.02) -0.9 (.01) -0.9 (.01)
2 3 -0.5 (.16) 0 (1) -0.1 (.78) 0 (1) 0 (1)
2 4 -1.2 (< .001) -2 (< .001) -1.6 (< .001) -1.6 (< .001) -1.4 (< .001)
2 5 -0.4 (.26) -0.4 (.26) -0.2 (.57) -0.1 (.78) -0.2 (.57)
2 6 -0.7 (.049) -1.1 (.002) -0.8 (.02) -0.9 (.01) -0.9 (.01)
3 4 -0.7 (.049) -2 (< .001) -1.5 (< .001) -1.6 (< .001) -1.4 (< .001)
3 5 0.1 (.78) -0.4 (.26) -0.1 (.78) -0.1 (.78) -0.2 (.57)
3 6 -0.2 (.57) -1.1 (.002) -0.7 (.049) -0.9 (.01) -0.9 (.01)
4 5 0.8 (.03) 1.6 (< .001) 1.4 (< .001) 1.5 (< .001) 1.2 (< .001)
4 6 0.5 (.16) 1.6 (< .001) 0.8 (.03) 0.7 (.49) 0.5 (.16)
5 6 -0.3 (.40) -0.7 (.049) -0.6 (.09) -0.8 (.02) -0.7 (.049)
*  Treatment groups are described in Table 1. Mean AE scores were compared between treatment groups listed in the first two columns 
for each of the five intestinal segments assessed. Sample sites were duodenum (W1), proximal jejunum (W2), mid jejunum (W3), distal 
jejunum (W4), and ileum (W5).
†  P refers to the P value for the difference in mean AE scores between the two groups listed on each row, generated from Tukey’s adjustment 
for multiple comparisons. Pooled standard error was 0.4. P values < .05 (bold print) were considered statistically significant.
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with B subtilis C-3102 after PEDV challenge 
did not alter fecal virus shedding. Groups 1, 
2, and 3 remained PEDV-negative through-
out the trial, thus the PEDV-positive and 
PEDV-negative cell culture inoculum was 
successfully administered without cross-
contamination at or after inoculation.
The 23-day ADG was lower than industry 
standards of 250 to 350 g per day for nursery 
pigs for the first 3 weeks post weaning.22 
Conventionally, pigs are weaned at 21 days, 
but pigs were weaned at 14 days of age for 
this study. Clinical signs of PEDV (diarrhea, 
dehydration, mortality, and depression) are 
age dependent.1,2 As the goal of the study 
was to produce a successful PEDV infec-
tion with enteric lesions, 14-day-old pigs, 
in lieu of 21-day-old pigs, were utilized in 
this study. Technical representatives for 
Calpis Co Ltd and Quality Technology In-
ternational recommended feeding B subtilis 
C-3102 continuously for approximately 
3 weeks prior to PEDV challenge to provide 
optimal opportunity for the product to im-
pact the gut. This extended feeding period 
could negatively impact clinical severity of 
PEDV challenge by increasing pig age at 
challenge, thus it was elected to start the trial 
with a younger pig, at the age of 14 days.  
There were no differences in SIWB or SIL 
between the groups. Small intestinal weight-
body weight was impacted by the volume 
and composition of intestinal ingesta. De-
spite the large potential for variability, the 
mean SIWB did not differ between groups, 
and there was also no difference between 
groups for SIL. The SILs determined in this 
study are comparable to SILs in 35- and 
39-day-old pigs.23,24  The functional signifi-
cance of SIL is related to digestion capacity 
to maximize growth and is strongly related 
to pig age and growth rate.24 As ADG 
increases with days on feed in the growing 
period,24 a difference in SIL between groups 
might have been appreciated if the duration 
of the study had been extended.
Fecal scores for all groups did reflect mild 
looseness in the stool; however, there was no 
difference in fecal scores between groups. This 
finding indicates that PEDV status is not cor-
related with visual fecal scores in weaned pigs 
under the conditions of this study. As PEDV 
status is critical to personnel, equipment, 
trucking logistics, and biosecurity, the results 
of the fecal score analysis highlight the im-
portance of conducting diagnostic testing to 
ascertain the PEDV status of weaned pigs.
The cecum and colon DM were measured 
to provide an objective assessment for fecal 
consistency. Keeping PEDV status constant, 
cecum DM did not differ significantly be-
tween diet groups. Disease status did impact 
cecum DM, but not colon DM in this study, 
as Group 1 and Group 4 did not differ sig-
nificantly in colon DM. For future PEDV 
studies, cecum DM appears to have more 
utility than colon DM in reflecting disease-
associated changes in fecal consistency.
The findings of this study support an associa-
tion between feeding B subtilis C-3102 and 
mitigating severity of PEDV lesions, includ-
ing lower IHC scores, lower AE scores, and 
higher VCRs at 4 dpi in nursery pigs chal-
lenged with PEDV, compared to cohorts that 
did not receive B subtilis C-3102. However, 
amount of virus shedding at 4 dpi did not 
differ with B subtilis C-3102 feeding. The 
results did appear to show that Group 5 ani-
mals benefited more than Group 6 animals 
Table 5: Pairwise comparison of mean cecum and colon DM percent between treatment groups*
Groups
Difference in mean 
cecum DM (%)
P value for cecum DM  
comparison between groups†
Difference in mean 
colon DM (%)
P value for colon DM comparison 
between groups†
1 2 0.28 1.00 1.25 .74
1 3 -0.23 1.00 0.83 .93
1 4 3.37 .01 2.71 .15
1 5 1.77 .16 5.89 < .01
1 6 1.61 .22 1.55 .57
2 3 -0.51 .95 -0.42 1.00
2 4 3.09 .02 1.46 .62
2 5 1.49 .27 4.65 .02
2 6 1.33 .36 0.30 1.00
3 4 3.60 < .01 1.88 .40
3 5 2.00 .11 5.06 .01
3 6 1.84 .14 0.72 .96
4 5 -1.60 .22 3.19 .08
4 6 -1.76 .16 -1.16 .79
5 6 -0.16 1.00 -4.35 .02
*  Treatment groups are described in Table 1. Mean differences in colon and cecum percent DM calculated by subtracting the mean cecal or 
colon dry matter percentage in column two from the percentage in column one.
† P values were generated from Tukey’s adjustment for multiple comparisons. Pooled standard error of cecum DM content was 0.61% and of 
colon DM was 0.91%. P values < .05 (bold print) were considered statistically significant.
DM = dry matter.
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from treatment with B subtilis C-3102. The 
study was not designed to measure dose-
dependent effects of B subtilis C-3102, 
and an additional study with this purpose 
would be needed to ascertain if differences 
between Group 5 and Group 6 were truly 
due to a dose-dependent or random effect. 
The impact of these parameters on morbid-
ity, mortality, amount and duration of virus 
shedding, ADG, and feed efficiency during 
the entire growing period is unknown and 
should be assessed with an additional study 
of longer duration and larger sample size. In 
a field scenario, it would be rare for DFM 
administration to precede an enteric disease 
outbreak by at least 2 weeks. If exposure to 
B subtilis C-3102 before PEDV exposure 
is critical to impact enteric lesions, then 
application in a field scenario may be chal-
lenging, as it would require administration 
to all groups or the identification of “at risk” 
groups for pre-emptive feeding.
Implications
•	 Under	the	conditions	of	this	study,	
there is no grossly detectable difference 
in fecal consistency between PEDV-
positive and PEDV-negative pigs fed 
the direct-fed microbial B subtilis 
C-3102.
•	 Pigs	that	receive	B subtilis C-3102 prior 
to PEDV challenge have lower PEDV 
IHC scores and better histopathology 
scores and villus-to-crypt ratios after 
PEDV challenge, compared to control 
cohorts.
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